The Cooper Companies, Inc.
COO
주식 순위
#1887
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
주가
$59.03
마지막 동기화: 2026-10-20
시가총액
$11.23B
변동 (1일)
1.50%
변동 (1년)
-21.29%
국가
US
거래 The Cooper Companies, Inc. (COO)
카테고리
Healthcare
The Cooper Companies, Inc. (COO)의 매출
Jul 2026 기준 매출 TTM: $4.24B
The Cooper Companies, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $4.24B입니다. 2024년에 회사는 $3.90B의 수익을 올렸으며 이는 2023년의 $3.59B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
The Cooper Companies, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $4.24B | 3.53% |
| 2025 | $4.09B | 5.06% |
| 2024 | $3.90B | 8.41% |
| 2023 | $3.59B | 8.61% |
| 2022 | $3.31B | 13.20% |
| 2021 | $2.92B | 20.22% |
| 2020 | $2.43B | -8.39% |
| 2019 | $2.65B | 4.76% |
| 2018 | $2.53B | 18.41% |
| 2017 | $2.14B | 8.75% |
| 2016 | $1.97B | 9.45% |
| 2015 | $1.80B | 4.62% |
| 2014 | $1.72B | 8.19% |
| 2013 | $1.59B | 9.87% |
| 2012 | $1.45B | 8.59% |
| 2011 | $1.33B | 14.87% |
| 2010 | $1.16B | 7.23% |
| 2009 | $1.08B | 1.62% |
| 2008 | $1.06B | 11.84% |
| 2007 | $950.64M | 10.67% |
| 2006 | $858.96M | 6.49% |
| 2005 | $806.62M | 64.56% |
| 2004 | $490.18M | 19.04% |
| 2003 | $411.79M | 30.60% |
| 2002 | $315.31M | 34.42% |
| 2001 | $234.57M | 18.88% |
| 2000 | $197.32M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $11.03B | 160.43% |
US
|
|
| $34.74B | 719.84% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 391.83% |
US
|
|
| - | - |
CH
|
